S usceptibility vessel sign (SVS) of the middle cerebral artery (MCA) on gradient-recalled echo (GRE) imaging was demonstrated to be well correlated with the hyperdense MCA sign on computed tomography. 1 Recently, an imagingpathology correlation study proved that both GRE SVS and computed tomographic hyperdense MCA sign represent red blood cell-dominant thrombi.
S usceptibility vessel sign (SVS) of the middle cerebral artery (MCA) on gradient-recalled echo (GRE) imaging was demonstrated to be well correlated with the hyperdense MCA sign on computed tomography. 1 Recently, an imagingpathology correlation study proved that both GRE SVS and computed tomographic hyperdense MCA sign represent red blood cell-dominant thrombi. 2 White thrombi composed of platelet-rich material displayed a relative resistance against intravenous thrombolysis, whereas red thrombi composed of erythrocyte-rich material showed a higher response rate. 3 Therefore, the presence of SVS may have a potential prognostic value related to recanalization. We evaluated the burden and morphology of SVS by using a contiguous, thin-slice (2 mm), 3-dimensional multiecho GRE sequence.
Subjects and Methods
We retrospectively reviewed our prospectively collected database for consecutive patients with acute ischemic stroke who received thrombolytic therapy between June 2009 and September 2013. We then included patients who (1) had a diagnosis of acute ischemic stroke confirmed by diffusion-weighted imaging; (2) received intravenous recombinant tissue-type plasminogen activator (r-tPA) <6 hours of symptom onset; (3) underwent GRE and time-of-flight magnetic resonance angiography before r-tPA infusion; (4) MCA occlusion without internal carotid artery involvement; (5) underwent follow-up time-of-flight magnetic resonance angiography 24 hours after r-tPA infusion.
All subjects underwent MRI on a 3.0-T system (Signa Excite HD). The GRE sequences were obtained with 11 equally spaced echoes: TE=4.5 ms (first echo); interecho spacing=4.5 ms; TR=58 ms; flip angle=20°; slice thickness=2.0 mm with no slice gap. SVS was defined as presence of hypointensity in MCA with a blooming artifact, that is, the diameter exceeded the hypointense signal in the homologous contralateral vessel diameter on GRE scans. 4 Two neurologists independently assessed the presence and features of SVS with rater discrepancies settled by consensus discussion. An irregular SVS was determined by thrombus tortuosity and branching ( Figure I in the online-only Data Supplement), which was described in detail in the previous study. 5 We used the arterial occlusive lesion scale to define recanalization or no recanalization based on the presence (grades 2 or 3) or absence (grades 0 or 1) of any downstream flow. 6 Fisher exact test was used to compare the dichotomous variables, whereas independent samples t test or Mann-Whitney U test was used for continuous variables, as appropriate. Variables with a P value <0.1 in univariate analyses were included in the logistic regression model. Statistical significance was set at a P value of <0.05.
Results
A total of 72 patients met study entry criteria. Mean age was 66±13 years, and 22 (30.6%) were women. Follow-up MRA revealed recanalization in 33 (45.8%) patients. SVS Background and Purpose-We aimed to evaluate the predictive value of susceptibility vessel sign (SVS) burden and morphology in middle cerebral artery recanalization. Methods-We retrospectively examined clinical and imaging data from 72 consecutive patients with acute ischemic stroke with middle cerebral artery occlusion and examined the association of recanalization with SVS length and shape. Results-None of the patients with a middle cerebral artery SVS >20 mm in length achieved recanalization. For patients with a relatively short SVS (length <20 mm), irregular shape was a strong independent predictor for no recanalization (odds ratio, 6.891; 95% confidence interval, Among the 17 patients with curved shape, the mean angle of curvature was 94±19° (range 62°-122°). Patients with M1 occlusion had more irregular SVS. Length of SVS was longer for the irregular than the regular morphologies (Table II in the online-only Data Supplement). For the patients with SVS length <20 mm, the recanalization rate for the irregular groups was 29.4% (versus 69.6% for the regular groups; P=0.024).
Both SVS length and irregular SVS were independently associated with no recanalization separately. The cutoff length of SVS was 14 mm. Interestingly, none of the patients with an MCA SVS >20 mm in length achieved recanalization 24 hours after intravenous thrombolysis (Figure) . For patients with a relatively short SVS (length <20 mm), irregular shape of SVS was still a strong independent predictor for no recanalization (odds ratio, 7.271; 95% confidence interval, 1.419-37.248; P=0.017; Table 2 ).
Discussion
We found that the presence of SVS itself did not predict recanalization in patients with MCA occlusion. Intravenous r-tPA had nearly no potential to achieve recanalization if MCA SVS length >20 mm, whereas irregular shape of SVS was then a strong predictor for no recanalization in patients with length of SVS <20 mm.
The previous controversial results about the predictive value of SVS for recanalization were mainly because of the methodological heterogeneity. Cho et al 7 found that SVS was an independent predictor of recanalization; however, only 27% of the included subjects received thrombolysis. Schellinger et al 8 indicated that SVS could not predict recanalization, but their study recruited all subtypes of ischemic stroke. Kimura et al 9 reported that M1 SVS was associated with no early recanalization. However, they enrolled the patients with internal carotid artery, M1, and M2 occlusions, but only evaluated the presence of M1 SVS, which resulted in a low incidence of SVS (22%), masking the significance of SVS itself.
Target clot burden, measured by thrombus length on computed tomography, has been shown to be an important determinant of recanalization with intravenous r-tPA. 10, 11 Similarly, we found that SVS length could predict recanalization after intravenous r-tPA infusion, too. We further found that straight and unbranched clots were recanalized 3× as often as clots that were curved or branched. A curved shape of the clot usually means that the thrombus fills the lumen of a tortuous MCA segment, which may represent thrombus growth. A branched shape indicates the presence of thrombus entering arterial branch segments, may also represent thrombus progression, and make it more difficult for r-tPA to penetrate into the clot through diffusion.
The optimal cutoff length of SVS is similar to the recent study, considering the blooming effect of GRE sequence. 12 None of the patients with an MCA SVS >20 mm in length achieved recanalization, which may indicate that immediate intra-arterial or endovascular therapy is the treatment of choice for these patients. For patients with SVS length <20 mm, the recanalization rate for the irregular groups was only 29.4%. 
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Additional need for ancillary endovascular therapy was then suggested in these patients in case of intravenous thrombolysis failure.
Limitations include a retrospective design, although we prospectively collected data using a stroke registry and MRI protocol, and a potential risk of selection bias. Second, GRE sequence is sensitive to motion artifact and noise, which could suggest curvature or branching where none was present. Third, the use of time-of-flight magnetic resonance angiography is somewhat inaccurate for distinguishing vessel occlusion from high-grade stenosis. Finally, the sample size was modest and was performed at a single center. Confirmation and extension in larger and multicenter cohorts is needed.
In summary, we concluded that irregular morphology and long length (>20 mm) of SVS on GRE decreased recanalization rate after intravenous thrombolysis in patients with MCA occlusion. Target thrombus length and morphology may be important predictors in the design of future clinical trials for acute ischemic stroke. 
